2 journalists jailed in Myanmar for exposing massacre of Rohingyas, finally freed

Agencies
May 7, 2019

Yangon, May 7: Two Reuters journalists who were under detention in Myanmar for more than 500 days after their conviction of breaking the Official Secrets Act on May 7, 2019 walked free from a prison on the outskirts of Yangon, witnesses said.

Wa Lone (33) and Kyaw Soe Oo (29) were convicted in September last and sentenced to seven years in jail. They were attested in December 2017. The case raised questions about Myanmar's progress toward democracy and sparked an outcry from diplomats and human rights advocates.

President Win Myint has pardoned thousands of other prisoners in mass amnesties since last month. It is customary in Myanmar for the authorities to free prisoners across the country around the time of the traditional New Year, which began on April 17.

Reuters has said the two men did not commit any crime and had called for their release.

Swamped by media and well-wishers as they walked through the gates of Insein Prison, on the outskirts of the commercial capital of Yangon, a grinning Wa Lone gave a thumbs up and said he was grateful for the international efforts to secure their freedom.

“I'm really happy and excited to see my family and my colleagues. I can't wait to go to my newsroom.”

Before their arrest, both had been working on an investigation into the killing of 10 Rohingya Muslim men and boys by security forces and Buddhist civilians in western Myanmar's Rakhine State during an army crackdown that began in August 2017. The operation sent more than 730,000 Rohingya fleeing to Bangladesh, according to U.N. estimates.

The report the two men authored, featuring testimony from perpetrators, witnesses and families of the victims, was awarded the Pulitzer Prize for international reporting in May, adding to a number of accolades received by the pair for their journalism. (https://reut.rs/2KFTSgQ)

Calls to a spokesman of the Myanmar government were not immediately answered.

Myanmar's Supreme Court rejected the journalists' final appeal in April. They had petitioned the country's top court, citing evidence of a police set-up and lack of proof of a crime, after the Yangon High Court dismissed an earlier appeal in January.

The reporters' wives wrote a letter to the government in April pleading for a pardon, not, they said, because their husbands had done anything wrong, but because it would allow them to be released from prison and reunited with their families.

“Months of dialogue”
The journalists were released at the prison to Lord Ara Darzi, a British surgeon and healthcare expert who has served as a member of an advisory group to Myanmar government, and a Reuters representative. Dr. Darzi waited for Wa Lone and Kyaw Soe Oo at the gates of the prison on a street where a group of dozens of reporters and photographers expecting a release of prisoners were also waiting.

In a statement to Reuters, Dr. Darzi (59), said their release came after months of dialogue with the government of Myanmar.

“I am delighted that they have been granted a pardon, released from custody, and are with their loved ones once more. I know that it will come as a huge relief to their families, friends and colleagues, Dr. Darzi said in the statement. This outcome shows that dialogue works, even in the most difficult of circumstances.

Dr. Darzi said discussions about the pardon for them had involved the Myanmar government, Reuters, the U.N. and representatives of other governments, but did not provide more detail on those closed-door talks.

Reuters had no immediate comment.

Dr. Darzi has been a member of an advisory commission that was formed to see through the advice from a panel headed by former UN chief Kofi Anan on solving the long-running conflict in Myanmars western region in the state of Rakhine.

Rakhine, on the Bay of Bengal, was the home to most Rohingya Muslims in Myanmar. Hundreds of thousands fled to Bangladesh after a military-led crackdown on the region in 2017.

Senior Myanmar government officials, diplomats and some international representatives are meeting in Yangon to discuss Rakhine this week.

The power of dialogue must be turned towards securing a lasting peace in Rakhine State and the return of the hundreds of thousands of refugees, whose desperate plight continues. This is essential if Myanmar is to build on todays progress so that all its citizens can live together in dignity in the hope of a better tomorrow, Dr. Darzi said in the statement.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 9,2020

London, May 9: Air India's first evacuation flight from London will be taking off for Mumbai today.

The screening of passengers is underway.

"Air India's first evacuation flight from London taking off for Mumbai today at 1200. Flight is 100% booked! Shubh Yatra. Please stay in touch. GoI working to send more evacuation flights!" High Commission of India, London said in a tweet.

On Monday, India announced had that it will begin phased repatriation of its citizens stranded abroad from May 7.

The government said that Air India will operate 64 flights in the first week from May 7 to May 13 to bring back around 15,000 Indian nationals.

On day three of the 'Vande Bharat Mission', flights carrying Indians from the Gulf countries, the United Kingdom, Bangladesh and Malaysia will arrive in India.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
February 26,2020

New Delhi, Feb 26: The death toll in northeast Delhi communal violence over the amended citizenship law rose to 20 on Wednesday, according to GTB Hospital authorities.

On Tuesday, the death toll was 13.

"The death toll has risen to 20 today," Medical Superintendent of GTB Hospital, Sunil Kumar, told PTI.

Earlier, at least four bodies were brought to the Guru Teg Bahadur Hospital from the Lok Nayak Jai Prakash Narayan Hospital, a senior official said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Beijing/Zurich, Mar 4: China has approved the use of Swiss drugmaker Roche's anti-inflammation drug Actemra for patients who develop severe complications from the coronavirus as it urgently hunts for new ways to combat the deadly infection that is spreading worldwide.

China is hoping that some older drugs could stop severe cytokine release syndrome (CRS), or cytokine storms, an overreaction of the immune system which is considered a major factor behind catastrophic organ failure and death in some coronavirus patients.

Actemra, a biologic drug approved in 2010 in the United States for rheumatoid arthritis (RA), inhibits high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.

China's National Health Commission said in treatment guidelines published online on Wednesday that Actemra can now be used to treat coronavirus patients with serious lung damage and high IL-6 levels.

Separately, researchers in the country are testing Actemra, known generically as tocilizumab, in a clinical trial expected to include 188 coronavirus patients and running until May 10.

Roche, which donated 14 million yuan ($2.02 million) worth of Actemra during February, said the trial was initiated independently by a third party with the aim of exploring the efficacy and safety of the drug in coronavirus patients with CRS.

It added that there was currently no published clinical trial data on the drug's safety or efficacy against the virus.

More than 3,000 people have died and 93,000 have been infected by the novel coronavirus thought to have originated in Wuhan, China, before spreading to around 90 countries including the United States, Italy, Switzerland, France and Germany.

The Swiss company, for which China is its No. 2 market behind the United States, also makes diagnostic gear to detect the coronavirus.

Since Actemra's approval a decade ago, it has become a go-to drug against other inflammatory conditions, including cytokine storms in cancer patients receiving cell therapies from Novartis and Gilead Sciences.

In 2012 it helped save the life of a young U.S. girl, the first child to be treated for leukaemia with Novatis' Kymriah, from a post-treatment rush of IL-6.

Priced at between $20-30,000 annually for RA according to SSR Health, Roche's medicine is also used for rare juvenile arthritis and giant cell arteritis, or inflammation of the blood vessels.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.